Login
Home
Charts
Search
Watchlist
Products

Samrat Pharmachem Ltd

SAMRATPH·BSE
₹224.90-0.46%Wed, 23 Sept '26 15:14
Industry:Pharmaceuticals Bulk Drugs
Indices:

Samrat Pharmachem Ltd

SAMRATPH
BSE
₹224.90
-0.46%
|Wed, 23 Sept '26 15:14
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹69Cr
Close
Close Price
₹224.90
Industry
Industry
Pharmaceuticals Bulk Drugs
PE
Price To Earnings
—
PS
Price To Sales
0.24
Revenue
Revenue
₹294Cr
Rev Gr TTM
Revenue Growth TTM
4.69%
PAT Gr TTM
PAT Growth TTM
-145.95%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
806283817064717679637280
Growth YoY
Revenue Growth YoY%
12.1-26.419.540.6-12.03.2-13.9-6.412.4-0.40.85.4
Expenses
ExpensesCr
806281786759717679647379
Operating Profit
Operating ProfitCr
001334000-1-11
OPM
OPM%
0.30.21.63.24.86.50.20.2-0.5-1.0-1.71.1
Other Income
Other IncomeCr
000100010001
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00134400-1-1-22
Tax
TaxCr
000111000001
PAT
PATCr
00123300-10-21
Growth YoY
PAT Growth YoY%
-103.2-83.8289.2239.31,500.0717.6-128.6-111.1-122.2-116.5-410.0482.6
NPM
NPM%
-0.20.61.72.63.84.4-0.6-0.3-0.8-0.7-2.81.1
EPS
EPS₹
-0.61.14.56.78.69.0-1.3-0.7-1.9-1.5-6.62.8
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
806283817064717679637280
Growth YoY
Revenue Growth YoY%
12.1-26.419.540.6-12.03.2-13.9-6.412.4-0.40.85.4
Expenses
ExpensesCr
806281786759717679647379
Operating Profit
Operating ProfitCr
001334000-1-11
OPM
OPM%
0.30.21.63.24.86.50.20.2-0.5-1.0-1.71.1
Other Income
Other IncomeCr
000100010001
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00134400-1-1-22
Tax
TaxCr
000111000001
PAT
PATCr
00123300-10-21
Growth YoY
PAT Growth YoY%
-103.2-83.8289.2239.31,500.0717.6-128.6-111.1-122.2-116.5-410.0482.6
NPM
NPM%
-0.20.61.72.63.84.4-0.6-0.3-0.8-0.7-2.81.1
EPS
EPS₹
-0.61.14.56.78.69.0-1.3-0.7-1.9-1.5-6.62.8

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
627193111137179222311282286290294
Growth
Revenue Growth%
30.514.930.220.123.730.223.940.1-9.41.51.44.7
Expenses
ExpensesCr
616787108131170198287279276292295
Operating Profit
Operating ProfitCr
1463792424210-2-1
OPM
OPM%
1.95.26.42.94.84.810.97.70.93.6-0.7-0.5
Other Income
Other IncomeCr
000010101111
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
000000111111
PBT
PBTCr
0352672423310-3-2
Tax
TaxCr
012122660301
PAT
PATCr
023245171727-3-2
Growth
PAT Growth%
-4.7482.383.4-52.3175.925.9222.2-3.2-87.0228.9-146.6-145.9
NPM
NPM%
0.52.53.51.43.13.07.85.30.82.5-1.1-0.8
EPS
EPS₹
1.05.710.45.013.717.355.653.87.023.0-10.7-7.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
627193111137179222311282286290294
Growth
Revenue Growth%
30.514.930.220.123.730.223.940.1-9.41.51.44.7
Expenses
ExpensesCr
616787108131170198287279276292295
Operating Profit
Operating ProfitCr
1463792424210-2-1
OPM
OPM%
1.95.26.42.94.84.810.97.70.93.6-0.7-0.5
Other Income
Other IncomeCr
000010101111
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
000000111111
PBT
PBTCr
0352672423310-3-2
Tax
TaxCr
012122660301
PAT
PATCr
023245171727-3-2
Growth
PAT Growth%
-4.7482.383.4-52.3175.925.9222.2-3.2-87.0228.9-146.6-145.9
NPM
NPM%
0.52.53.51.43.13.07.85.30.82.5-1.1-0.8
EPS
EPS₹
1.05.710.45.013.717.355.653.87.023.0-10.7-7.1

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
33333333333
Reserves
ReservesCr
1112151721274460626965
Current Liabilities
Current LiabilitiesCr
2019211934273753565056
Non Current Liabilities
Non Current LiabilitiesCr
22110000000
Total Liabilities
Total LiabilitiesCr
36364140585785117122121124
Current Assets
Current AssetsCr
2828333350477199103103104
Non Current Assets
Non Current AssetsCr
88879101318191821
Total Assets
Total AssetsCr
36364140585785117122121124
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
33333333333
Reserves
ReservesCr
1112151721274460626965
Current Liabilities
Current LiabilitiesCr
2019211934273753565056
Non Current Liabilities
Non Current LiabilitiesCr
22110000000
Total Liabilities
Total LiabilitiesCr
36364140585785117122121124
Current Assets
Current AssetsCr
2828333350477199103103104
Non Current Assets
Non Current AssetsCr
88879101318191821
Total Assets
Total AssetsCr
36364140585785117122121124

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-302-1517-99-109
Investing Cash Flow
Investing Cash FlowCr
-21-22-2-3-1-300-3
Financing Cash Flow
Financing Cash FlowCr
212-42-2-210-1100
Net Cash Flow
Net Cash FlowCr
0-1-11-1014-3-2-106
Free Cash Flow
Free Cash FlowCr
-1-402-2216-119-116
CFO To PAT
CFO To PAT%
-119.7-184.04.1154.5-31.390.0101.7-56.8435.2-141.9-268.1
CFO To EBITDA
CFO To EBITDA%
-30.1-87.72.274.7-20.055.472.1-39.4381.1-98.5-415.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-302-1517-99-109
Investing Cash Flow
Investing Cash FlowCr
-21-22-2-3-1-300-3
Financing Cash Flow
Financing Cash FlowCr
212-42-2-210-1100
Net Cash Flow
Net Cash FlowCr
0-1-11-1014-3-2-106
Free Cash Flow
Free Cash FlowCr
-1-402-2216-119-116
CFO To PAT
CFO To PAT%
-119.7-184.04.1154.5-31.390.0101.7-56.8435.2-141.9-268.1
CFO To EBITDA
CFO To EBITDA%
-30.1-87.72.274.7-20.055.472.1-39.4381.1-98.5-415.0

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
82439231942150115103976069
Price To Earnings
Price To Earnings
27.513.912.215.04.47.98.76.947.613.6
Price To Sales
Price To Sales
0.10.30.40.20.10.20.70.40.40.30.20.2
Price To Book
Price To Book
0.61.62.11.10.81.43.21.81.61.40.91.0
EV To EBITDA
EV To EBITDA
8.47.87.48.54.05.65.95.141.210.4-30.4-54.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
5.98.69.55.77.06.812.89.32.85.40.90.9
OPM
OPM%
1.95.26.42.94.84.810.97.70.93.6-0.7-0.5
NPM
NPM%
0.52.53.51.43.13.07.85.30.82.5-1.1-0.8
ROCE
ROCE%
5.015.621.012.320.322.444.729.14.412.9-2.6-2.6
ROE
ROE%
2.211.517.47.717.418.036.726.33.39.9-4.9-4.9
ROA
ROA%
0.84.97.93.87.39.320.314.31.85.8-2.7-2.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
82439231942150115103976069
Price To Earnings
Price To Earnings
27.513.912.215.04.47.98.76.947.613.6
Price To Sales
Price To Sales
0.10.30.40.20.10.20.70.40.40.30.20.2
Price To Book
Price To Book
0.61.62.11.10.81.43.21.81.61.40.91.0
EV To EBITDA
EV To EBITDA
8.47.87.48.54.05.65.95.141.210.4-30.4-54.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
5.98.69.55.77.06.812.89.32.85.40.90.9
OPM
OPM%
1.95.26.42.94.84.810.97.70.93.6-0.7-0.5
NPM
NPM%
0.52.53.51.43.13.07.85.30.82.5-1.1-0.8
ROCE
ROCE%
5.015.621.012.320.322.444.729.14.412.9-2.6-2.6
ROE
ROE%
2.211.517.47.717.418.036.726.33.39.9-4.9-4.9
ROA
ROA%
0.84.97.93.87.39.320.314.31.85.8-2.7-2.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Samrat Pharmachem Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/eqgmczqczceh2j5aaokid2kz.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/xuc6h93xf5wfm1kw8uz95thy.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/4lswlrucljpdv1rc8ktpggkc.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/wye0kc28uew30k5ivviqhg7p.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/buftpuyd3im8g8gjvnxulq1w.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/58n1i923h81aly3a8wy28vvb.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/175jtle2e67hez0k3533atc2.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/gez546tufdlninc04muo2vbj.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/l2y0mmvghpmir32glyow92jb.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/k7op6v0kcnf3s6gccqf75b6t.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/glf3uvydsja69n77cujt65mz.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/hwb5wfptt2d7t9aev0kt2opx.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/dci1oswi8m23l162qcgrokvr.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/mlrwah5u3e0ybrov9u7ztv2r.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/q4ivfpxfkzqzt7hufanhjqa7.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies